Decreased CCR2 and CD62L expressions on peripheral blood classical monocytes in amyotrophic lateral sclerosis

Clinical and Experimental Neuroimmunology

Volumn 5, Issue 1, 2014, Pages 92-96

  Cui, Yi Wen ^a   Kawano, Yuji ^a   Yamasaki, Ryo ^a   Shi, Nan ^a   Masaki, Katsuhisa ^a   Isobe, Noriko ^a   Yonekawa, Tomomi ^a   Matsushita, Takuya ^a   Tateishi, Takahisa ^a   Hayashi, Shintaro ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

amyotrophic lateral sclerosis; CCR2; CD62L; flow cytometry; monocyte

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; L SELECTIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MIDDLE AGED; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE;

EID: 84895488375     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12088     Document Type: Article

References (21)

1. Henkel JS, Engelhardt JI, Siklos L, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004; 55: 221-35.
2. Mantovani S, Garbelli S, Pasini A, et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol. 2009; 210: 73-9.
3. Tateishi T, Yamasaki R, Tanaka M, et al. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol. 2010; 222: 76-81.
4. Shi N, Kawano Y, Tateishi T, et al. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate. J Neuroimmunol. 2007; 182: 232-5.
5. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116: e74-80.
6. Tacke F, Randolph GJ,. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006; 211: 609-18.
7. Brooks BR,. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994; 124 (Suppl): 96-107.
8. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13-21.
9. Tanaka M, Kikuchi H, Ishizu T, et al. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2006; 65: 816-25.
10. Cui YW, Kawano Y, Shi N, et al. Alterations in chemokine receptor expressions on peripheral blood monocytes in multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol. 2013; 4: 201-205.
11. Zhang R, Gascon R, Miller RG, et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2006; 179: 87-93.
12. Geissmann F, Jung S, Littman DR,. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003; 19: 71-82.
13. Szczepanik AM, Funes S, Petko W, et al. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol. 2001; 113: 49-62.
14. Nockher WA, Scherberich JE,. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun. 1998; 66: 2782-90.
15. Saionji K, Ohsaka A,. Expansion of CD4+ CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta Haematol. 2001; 105: 21-6.
16. Katayama K, Matsubara T, Fujiwara M, et al. CD14+ CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 2000; 121: 566-70.
17. Emminger W, Zlabinger GJ, Fritsch G, et al. CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. Eur J Immunol. 2001; 31: 1716-9.
18. Nockher WA, Bergmann L, Scherberich JE,. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol. 1994; 98: 369-74.
19. Capsoni F, Minonzio F, Ongari AM, et al. Fc receptors expression and function in mononuclear phagocytes from AIDS patients: modulation by IFN-gamma. Scand J Immunol. 1994; 39: 45-50.
20. Kira J,. Neuroinflammation in neurological disorders. In:, Suzumura A, Ikenaka K, eds. Neuron-glia Interaction in Neuroinflammation. New York: Springer; 2013: 21-48.
21. De Martinis M, Modesti M, Ginaldi L,. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from elderly persons. Immunol Cell Biol. 2004; 82: 415-20.